Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months

  • Mieko Masumoto, Masato Wakakura, Goji Tomita, Kenji Inoue
  • Clinical Ophthalmology, March 2011, Taylor & Francis
  • DOI: 10.2147/opth.s17527

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/opth.s17527